Veracyte Inc (12V.SG)
| Previous Close | 19.50 |
| Open | 19.20 |
| Bid | 19.30 x 0 |
| Ask | 19.70 x 0 |
| Day's Range | 19.20 - 19.20 |
| 52 Week Range | 17.50 - 26.80 |
| Volume | |
| Avg. Volume | 2 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
What Makes Veracyte (VCYT) a Lucrative Investment?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here. The recent surge in the stock market highlights the significance of current macroeconomic indicators and the Fed’s outlook on future interest rates. The strategy returned 9.54% (net of fees) compared to […]
- Simply Wall St.
Veracyte Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Veracyte ( NASDAQ:VCYT ) Full Year 2023 Results Key Financial Results Revenue: US$361.1m (up 22% from FY 2022). Net...
- Insider Monkey
Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript
Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript February 22, 2024 Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you […]
